Skip to main content
OpenTrials

Clinical trial condition

Prostatic Diseases

Explore clinical trials studying Prostatic Diseases. Study availability and eligibility vary by location and protocol.

5,367 public trials 1,047 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Diseases trial results

Recruiting

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

NCT06150417

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations
  • University Hospitals Cleveland Medical Center Seidman Cancer Center Cleveland, Ohio, United States
  • Carbone Cancer Center University of Wisconsin-Madison Madison, Wisconsin, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

NCT04423211

Conditions
Biochemically Recurrent Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
View all 341 locations
View Trial Details
Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

NCT06855277

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Urology Centers Of Alabama Pc Homewood, Alabama, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • Sansum Clinic Santa Barbara, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
View all 92 locations
View Trial Details
Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT03866382

Conditions
Adenocarcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, +71 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 581 locations
View Trial Details

Related conditions